What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?
Expert Rev Anticancer Ther
.
2023 May;23(5):455-459.
doi: 10.1080/14737140.2023.2200939.
Epub 2023 Apr 13.
Authors
Takafumi Yanagisawa
1
2
,
Manuela Schmidinger
1
,
Harun Fajkovic
1
3
,
Pierre I Karakiewicz
4
,
Takahiro Kimura
2
,
Shahrokh F Shariat
1
3
5
6
7
8
Affiliations
1
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
2
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
3
Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
4
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
5
Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan.
6
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
7
Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
8
Department of Urology, Weill Cornell Medical College, New York, NY, USA.
PMID:
37042747
DOI:
10.1080/14737140.2023.2200939
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Renal Cell* / surgery
Cytoreduction Surgical Procedures
Humans
Kidney Neoplasms* / pathology
Kidney Neoplasms* / surgery
Nephrectomy
Retrospective Studies